News on our collaborations within EU Horizon 2020 projects: BRAINTEASER at the Brain Innovation Days 2022
BRAINTEASER takes part in the Brain Innovation Days 2022 The second edition of the Brain Innovation Days took place on 11-12 October 2022 in Brussels (Belgium) and featured BRAINTEASER as one of the exhibitors in the Innovation Hall. This year’s edition of the event … Read More
Successes and Opportunities in Modeling & Simulation for FDA
The use of in silico trials is expected to play an increasingly important role in the development and regulatory evaluation of new drugs and medical devices. One of the advantages that in silico approaches offer is the possibility to test … Read More
News on our collaborations within EU Horizon 2020 projects: BRAINTEASER at DHSS 2022
BRAINTEASER contribution to the DHSS 2022 The Digital Health Society Summit 4th edition, that took place virtually on October 4th and 5th 2022, has seen the contribution of BRAINTEASER in two relevant panel discussions: “How do you maximise the use of Health … Read More
Shedding light on Digital Twin, Digital Patient, Virtual Patient and Synthetic Control Arm
The scope of this white paper is to clarify the different definitions of Digital Twin, Digital Patient, Virtual Patient and Synthetic Control Arm in the Pharma and MedTech fields. Please read more about it here: https://insilicotrials.com/white-papers/
News on our collaborations within EU Horizon 2020 projects: BRAINTEASER interview with Nicola Ferro
An Interview with Nicola Ferro: Discovering The iDPP@CLEF Challenge 2022 For those of us who don’t know much about CLEF, can you tell us more about what it comprises and how the iDPP@CLEF Challenge plays a role? Of … Read More
How to accelerate the uptake of simulation in healthcare
In Silico World is one of the three Horizon 2020 funded projects InSilicoTrials Technologies is part of. We are in a consortium of 17 international partners, coordinated by the University of Bologna, that will receive €7.6 million funds by the European Commission to develop 11 in silico trials solutions leveraging state-of-the-art computational technologies to … Read More
Simulation to help fight cardiovascular disease
Simulation to help fight cardiovascular disease. As we all know, cardiovascular disease (CVD) is the leading cause of death worldwide, with 18 million deaths each year according to WHO estimates. Currently, 15 million people in Europe live with heart failure. You can see why we were so … Read More
How to accelerate safety and performance assessments of 3D-printed PPE at POC
New simulation standards can accelerate safety and performance assessments of 3D-printed personal protective equipment (PPE), especially during global emergencies: this was the starting point of our participation in the ASTM Workshop on Fast-Tracking Standards Development to Address PPR Shortages due … Read More
Towards Good Simulation Practice
During the 2020 Avicenna Day, many experts from all over the world talking about the need for Good Simulation Practice, a term coined by the Avicenna Alliance taking inspiration from the Good Clinical Practice typical of the clinical world to … Read More